FDA inspection

Natco Pharma Limited: FDA inspection ending Mar 30, 2020

FDA inspection 1123348 · No Action Indicated (NAI) · Paravada

Key facts

Inspection ID 1123348
Firm Natco Pharma Limited
FEI number 3015380536
Address Plots 89 - 90, Ramky Pharma City; Jnpc Sez
City Paravada
Fiscal year 2020
Inspection end date Mar 30, 2020
Classification No Action Indicated (NAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections